Skip to content

Evaluation of the systemic use of Lycopene supplementation on non-surgical periodontal treatment

Evaluation of the systemic use of Lycopene supplementation on non-surgical periodontal treatment

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230830059303N1
Enrollment
42
Registered
2023-09-09
Start date
2023-10-22
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic periodontitis. Chronic periodontitis

Interventions

Intervention 1: Intervention group: Lycopene. Intervention 2: Control group: placebo.

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 55 Years

Inclusion criteria

Inclusion criteria: the patient is systematically healthy CAL is more than 3 mm and clinical signs of gingivitis such as erythema and BOP are present. The patient should not smoke cigarettes or other types of tobacco products. The patient does not have any history of periodontal treatment in the last 6 months. Absence of disease or systemic conditions that interfere with wound healing. Absence of inflammatory conditions in the oral mucosa such as aphthous ulcers and lichen planus and acute allergic reactions Not using drugs that affect periodontium (anticonvulsants, calcium channel blockers and immunosuppressors) Not taking antioxidant supplements such as Vitamin C or melatonin Not allergic to tomatoes The patient should not be treated with radiotherapy etc. Not being pregnant or breastfeeding or not receiving hormonal drugs Not taking anti-inflammatory drugs such as ibuprofen and...

Exclusion criteria

Exclusion criteria: Non-attendance of the patient in the follow-up sessions Failure to follow instructions for taking oral lycopene supplements Failure to observe oral hygiene

Design outcomes

Primary

MeasureTime frame
Clinical attachment level. Timepoint: baseline , 4weeks and 8 weeks after using supplement. Method of measurement: periodontal probe.;Periodontal pocket depth. Timepoint: baseline, 4weeks and 8 weeks after using supplement. Method of measurement: periodontal probe.;Bleeding index. Timepoint: baseline, 4weeks and 8 weeks after using supplement. Method of measurement: percentage of bleeding sites.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaezeh Sadeghi Heris

Yazd University of Medical Sciences

sdgh.f4@gmail.com+98 911 766 2640

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026